CTSO
Cytosorbents Crp
4.40$
+1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.9% | -13.9% | +148.6% | +35.9% | -16.4% | +228.5% | -0.5% | -29.4% | -15.8% | -11.1% | -6.7% | |
| – | +29.6% | -20.6% | +164.9% | +36.3% | -26.0% | +294.5% | -22.0% | -47.5% | -23.9% | -15.9% | -4.5% | |
| – | +47.5% | -1.3% | +230.2% | +29.1% | -45.3% | +483.8% | -27.0% | -57.5% | -36.2% | -76.8% | +90.5% | |
| – | +35.3% | -30.1% | +230.2% | +29.1% | -45.3% | +483.8% | -27.0% | -57.5% | -36.2% | -76.8% | +90.5% | |
| – | -20.8% | +120.9% | +53.9% | +78.8% | +13.3% | +15.5% | -12.3% | +25.2% | +6.9% | +20.8% | +3.1% | |
| – | +121.3% | -30.0% | -4.6% | +4.7% | +153.7% | +26.5% | +78.3% | -27.4% | +6.3% | -25.7% | +93.2% | |
| – | +126.5% | +2.2% | +146.4% | +126.6% | -5.8% | -29.2% | +776.2% | -42.2% | – | – | – | |
| – | +38.4% | +54.3% | +54.3% | +42.8% | +28.0% | +25.6% | – | – | – | – | – | |
| – | +38.4% | +54.3% | +54.3% | +42.8% | +28.0% | +25.6% | +11.4% | -6.6% | -11.0% | -4.1% | -13.9% | |
| – | -32.5% | +234.1% | +36.1% | +14.2% | +51.6% | -55.2% | +151.0% | +3.4% | +7.6% | +20.9% | +5.6% | |
| – | -32.5% | +100.1% | +28.9% | -16.7% | +52.0% | +2.2% | +34.8% | -29.0% | +49.7% | -32.5% | -1.2% | |
| – | -20.5% | +27.1% | +380.0% | -83.3% | +278.4% | -82.3% | +27.5% | -80.9% | +2,537.8% | -84.2% | +19.5% | |
| – | -2.0% | +94.3% | -6.4% | +58.0% | +3.7% | +21.0% | +13.7% | -41.0% | +129.7% | -12.2% | -14.1% | |
| – | – | – | +46.9% | +54.8% | +44.3% | – | – | – | -49.1% | +450.4% | +19.1% | |
| – | +107.2% | -105.8% | – | +65.0% | -79.8% | +2,217.6% | -21.0% | -43.5% | -34.2% | -52.3% | -46.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +73.0% | +2.2% | +8.6% | +11.2% | +5.0% | +20.3% | +11.7% | -95.0% | +2.5% | +21.9% | +14.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.